Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EMD Serono names VP, medical affairs

This article was originally published in Scrip

Executive Summary

Rockland, Massachusetts-based EMD Serono, the US biopharmaceuticals subsidiary of Germany's Merck KGaA, has appointed Dr Frederick E Munschauer vice-president of medical affairs, neurology and immunology. In this capacity, Dr Munschauer will lead the medical affairs activities for clinical, commercial and business development projects and collaborations for Rebif (interferon beta-1a) as well as the company’s immunology and neurology pipeline. He joins EMD Serono from Biogen, where he was chief medical advisor.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts